Vivekam's Shariah Products (2026): TASIS Certification From Rs 5,000 a Month

The most underpriced fact in Indian halal investing: the TASIS-approved stock universe, the same certified screening that Geojit sells at a Rs 50 lakh PMS minimum, is available through Vivekam Financial Services from Rs 50,000 as a lumpsum or Rs 5,000 a month as a SIP. Vivekam appears on TASIS's own certified-clients ledger for 2025, completing the two-way verification loop that only two Indian firms manage. This review covers both Shariah products, the firm behind them, and the caveats that keep this from being an unqualified recommendation. Crawled vivekam.co.in and tasis.in 2026-08-06.

The firm

Vivekam is a Hyderabad advisory established in 2010, holding SEBI Registered Investment Adviser registration INA200000316, Portfolio Manager registration INP000009481, and BASL enlistment 1288. It is a quantitative shop: model-driven stock selection applied across a conventional product shelf (its flagship products include BIO-Growth and Wifty) plus the Shariah line reviewed here. Fifteen years under SEBI advisory regulation is meaningful operating history in a cluster full of young firms.

The Shariah products

Shariah - Growth is the lumpsum product: minimum Rs 50,000, building growth-stock portfolios exclusively from stocks approved by TASIS (Mumbai). Vivekam's page states it plainly: Vivekam Sharia products only deal in those stocks which are approved by TASIS. Entry mechanics are a printed differentiator: investment is split into four tranches to avoid buying at highs, a discipline most advisers describe vaguely and Vivekam commits to specifically. Shariah SMILES is the SIP variant: the same TASIS universe through monthly instalments of Rs 5,000 minimum, mirroring the firm's popular SMILES - Growth product in mechanics. Both products put stocks directly in your own demat account, and both sit under the firm's advisory registrations rather than pooled structures.

Why the certification matters here specifically

TASIS is India's de facto Shariah standards body: its screens power NSE's Nifty Shariah indices, its thresholds (interest-based debt at or below 25% of total assets, interest income at or below 2.5% of total income) are the most conservative in mainstream Indian use, and its certified-clients page is publicly checkable. Vivekam Financial Services Private Ltd appears on that page with a 2025 certification year. The practical meaning: when you buy Vivekam's Shariah products, your compliance assurance is the same bench of scholars (Barkatulla, Rahmani, Al-Nadwi) that stands behind Tata Ethical Fund and the Shariah BeES ETF's underlying index, at a fraction of institutional entry prices. No other retail-priced product in India prints that chain.

The caveats, all three of them

First, the mixed house: Vivekam's main shelf is conventional, and it includes derivatives advisory, which is about as far from Shariah preference as advisory products get. The Shariah line is a product family, not the firm's identity; if firm-level purity is your first filter, SenSage (fully halal-dedicated, unnamed board) or Zamzam Capital (fully halal-dedicated, named board) are the alternatives, at Rs 3 lakh and app-gated smallcase pricing respectively. Second, fees: advisory fees for the Shariah variants are not printed on the products page. Vivekam publishes separate PMS pricing for its PMS products, but for these advisory products you must get the current fee schedule in writing before onboarding. Third, purification: no administration or reporting of impure income is described; computing and donating the impure sliver of your dividends is your job, and our purification guide shows how the screening apps make it manageable.

Who this suits

Shariah SMILES answers the question most Indian Muslim savers actually ask: how do I start halal equity with salary money rather than accumulated savings? At Rs 5,000 a month with externally certified screening, nothing else in India competes on entry price with verification: Green Portfolio's smallcase minimum floats around Rs 53,000, Zamzam's pricing is app-gated, SenSage starts at Rs 1 lakh, and the PMS options start at Rs 50 lakh. Shariah - Growth suits investors with Rs 50,000+ who want the four-tranche discipline. Both suit certification-first investors specifically; dedication-first investors should shop the halal-native firms, and fund-first investors should note that Tata Ethical's Rs 100 SIP remains the cheapest certified entry of all, with purification published, though without personalised advisory.

Verdict

Vivekam's Shariah line is the price-performance sweet spot of Indian halal advisory: TASIS's universe, verifiable on the certifier's own site, from Rs 5,000 a month, delivered with printed entry mechanics by a fifteen-year-old SEBI-registered quant shop. The unprinted fees are an annoyance you can resolve with one email; the mixed-house character and DIY purification are structural trade-offs you should weigh honestly. If external certification at retail money is what you want, this is where India currently sells it. Verified 2026-08-06.

The four-tranche entry, explained

Vivekam's most distinctive printed mechanic deserves unpacking. Rather than deploying your Rs 50,000+ lumpsum on day one, the firm splits entry into four tranches, staggering purchases to avoid concentrating your cost basis at a single day's prices. In an unscreened portfolio this is ordinary prudence; in a screened universe it is worth more, because compliant Indian portfolios concentrate in fewer sectors and swing harder, as the year to June 2026 demonstrated (the screened flagship index fell -13.35% against the market's -5.42%). Staggered entry converts some of that volatility from risk into averaging. The SMILES SIP variant takes the same logic to its conclusion: every month is a tranche, permanently. Neither mechanic changes the Shariah analysis (each tranche is a spot purchase of certified-universe stocks), but both change the experience of owning the result, which is what keeps investors invested.

Frequently asked questions

Is Vivekam's certification real? Yes, and verifiable two ways: Vivekam's page states its Sharia products deal only in TASIS-approved stocks, and TASIS's certified-clients ledger lists Vivekam Financial Services Private Ltd for 2025. Re-check the ledger annually; the Taurus precedent shows why. What exactly do I own? Direct stocks in your own demat account, selected by Vivekam's quantitative engine from the TASIS universe; the firm advises, you hold. What does it cost? Not printed for the Shariah variants, which is our standing complaint; get the current schedule in writing before onboarding and weigh it against Zamzam's flat smallcase subscription and SenSage's fee-based model. Does the derivatives advisory elsewhere in the firm contaminate the Shariah products? Structurally no: your account holds your screened stocks, and the firm's other clients' activities are not your transactions. Philosophically, investors who want their adviser's whole business halal have SenSage and Zamzam as the halal-native alternatives; that fork is real and personal. Who should pick Vivekam? Certification-first investors at retail scale: nothing else in India combines a verifiable TASIS chain with Rs 5,000 monthly entry, and that combination is this firm's entire, sufficient case. Verified 2026-08-06.

How Vivekam compares with the alternatives

Against the rest of India's Shariah advisory field, Vivekam's distinguishing feature is its quantitative, model-driven approach. SenSage leads with Shariah-first branding, Green Portfolio with its fee structure, and Geojit with TASIS certification and a listed parent. Vivekam leads with process automation. Whether that appeals depends on what you believe drives returns: a systematic model applied consistently, or discretionary judgment. Neither is more or less halal than the other, provided the screening layer is sound.

The screening layer is therefore the thing to verify. Ask which Shariah methodology filters the investable universe before the quantitative model runs, how often the filter refreshes, and what happens to a holding that turns non-compliant mid-cycle. A quantitative engine that rebalances monthly but re-screens annually can hold a non-compliant stock for months. The firm should be able to answer this in one email. If it cannot, the certified funds remain the cleaner choice. Verified August 2026.